Author

Reinier C. A. van Linschoten 1

1 Erasmus Medical Centre, Rotterdam, Netherlands

CLINICAL OUTCOMES OF INCREASED VERSUS CONVENTIONAL ADALIMUMAB DOSE INTERVALS IN PATIENTS WITH CROHN’S DISEASE IN STABLE REMISSION: THE RANDOMISED CONTROLLED LADI TRIAL

Reinier C. A. van Linschoten, Fenna Minke Jansen, Renske W. M. Pauwels, Lisa J. T. Smits, Femke Atsma, Wietske Kievit, Paul Boekema, Rachel West, Alexander G. L. Bodelier, Ingrid A. M. Gisbertz, Frank H. J. Wolfhagen, Tessa E. H. Römkens, Maurice W. M. D. Lutgens, Adriaan A. Van Bodegraven, Bas Oldenburg, Marieke Pierik, Ma

COST-EFFECTIVENESS ANALYSIS OF INCREASED ADALIMUMAB DOSE INTERVALS IN PATIENTS WITH CROHN’S DISEASE IN STABLE REMISSION: ECONOMIC EVALUATION OF THE RANDOMISED CONTROLLED LADI TRIAL

Fenna Minke Jansen, Reinier C. A. van Linschoten, Renske Wilhelmina Maria Pauwels, Lisa S. Smits, Wietske Kievit, Paul Boekema, Rachel West, Alexander G. L. Bodelier, Ingrid A. M. Gisbertz, Frank H. J. Wolfhagen, Tessa E.H. Römkens, Maurice W. M. D. Lutgens, Adriaan A. Van Bodegraven, Bas Oldenburg, Marieke Pierik, Maurice G

COST-EFFECTIVENESS ANALYSIS OF INCREASED ADALIMUMAB DOSE INTERVALS IN PATIENTS WITH CROHN’S DISEASE IN STABLE REMISSION: ECONOMIC EVALUATION OF THE RANDOMISED CONTROLLED LADI TRIAL

Reinier C. A. van Linschoten

Item 1 - 3 / 3
1